TRPM8 and prostate cancer: These include TRPM8 (transient receptor potential melastatin member 8), a putative prognostic marker and therapeutic target in prostate cancer [34], [35], ACPP (prostatic acid phosphatase) [36], SCGB1A1 (uteroglobin) [37], NDRG1 (N-myc downstream regulated gene 1) [38], and CREB3L4 (cAMP responsive element binding protein 3-like 4) [39].